Amphenol stock posted strong Q3 results and boosted its dividend. Click here for more on APH's growth drivers, recent ...
News-Medical.Net on MSN
Revolutionizing lipid nanoparticle formulations for targeted treatments
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines ...
The findings reveal that LNPs come in a surprising variety of configurations and the differences correlate with their delivery capabilities.
Fintel reports that on October 23, 2025, Truist Securities maintained coverage of Amphenol (NYSE:APH) with a Buy ...
The CCS acquisition followed the sale of CommScope’s mobile networks business to Amphenol for $2.1 billion in mid-2024.
Fintel reports that on October 23, 2025, Goldman Sachs maintained coverage of Amphenol (NYSE:APH) with a Buy recommendation.
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines ...
AdvanSix's fundamentals remain strong despite recent volatility, with stable earnings and a well-covered 3.29% dividend. Read ...
The company is financially sound, with a market capitalization of $153 billion. In the previous year, Amphenol achieved ...
Amphenol Corp (NYSE: APH) reports record third-quarter 2025 results, with sales up 53% and adjusted EPS beating analyst ...
With growing concerns over fossil fuel depletion and the environmental impacts of petrochemical production, scientists are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results